Synthesis and antitumour activity of new daunorubicin and adriamycin analogues
- PMID: 570116
- DOI: 10.1007/BF01981401
Synthesis and antitumour activity of new daunorubicin and adriamycin analogues
Abstract
A new synthetic procedure for the preparation of daunorubicin and adriamycin analogues bearing different substituents on ring D, has been developed. The new compounds display outstanding efficacy against experimental tumours of mice.
Similar articles
-
Adriamycin analogs hydroxylated at c-3': synthesis and antitumor activity.Carbohydr Res. 1979 Dec;77:C8-C11. doi: 10.1016/s0008-6215(00)83825-2. Carbohydr Res. 1979. PMID: 519652 No abstract available.
-
Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone.J Med Chem. 1975 Jul;18(7):703-7. doi: 10.1021/jm00241a013. J Med Chem. 1975. PMID: 168385
-
New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.J Antibiot (Tokyo). 1985 Jul;38(7):856-67. doi: 10.7164/antibiotics.38.856. J Antibiot (Tokyo). 1985. PMID: 3861603
-
Anthracycline mechanisms in analogue selection.Drugs Exp Clin Res. 1985;11(1):1-8. Drugs Exp Clin Res. 1985. PMID: 3915272 Review.
-
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.Cancer Treat Rep. 1986 Jan;70(1):51-63. Cancer Treat Rep. 1986. PMID: 2935251 Review. No abstract available.
Cited by
-
Mechanochemical Friedel-Crafts acylations.Beilstein J Org Chem. 2019 Jun 17;15:1313-1320. doi: 10.3762/bjoc.15.130. eCollection 2019. Beilstein J Org Chem. 2019. PMID: 31293680 Free PMC article.
-
Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.Drugs. 1991 Oct;42(4):690-719. doi: 10.2165/00003495-199142040-00010. Drugs. 1991. PMID: 1723369 Review.
-
Phase II study of 4'-deoxydoxorubicin in advanced colorectal cancer.Invest New Drugs. 1986;4(2):165-9. doi: 10.1007/BF00194597. Invest New Drugs. 1986. PMID: 3733376
-
Phase II evaluation of esorubicin (4'deoxydoxorubicin) in pancreatic adenocarcinoma: a Southwest Oncology Group study.Invest New Drugs. 1990 Feb;8(1):81-5. doi: 10.1007/BF00216929. Invest New Drugs. 1990. PMID: 2188929 Clinical Trial.
-
A method for the simultaneous measurement of the new anthracycline derivative 4'-deoxydoxorubicin and its metabolites by reversed phase liquid chromatography.Invest New Drugs. 1984;2(3):277-80. doi: 10.1007/BF00175377. Invest New Drugs. 1984. PMID: 6511234
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources